Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

The Business Cocktail

The Business Cocktail

Aug 02, 2016

  • Juno Therapeutics recently acquired Redox Therapies and it’s vipadenant, a small molecule adenosine A2a (A2a) receptor antagonist. The upfront consideration for the Redox Therapies acquisition was $10 million in cash.
  • UK-based Cell Medica expands its T cell immunotherapy program with the acquisition of privately-held Delenex Therapeutics
  • Evelo Biosciences, US based Microbiome Company working in oncology through characterization of cancer associated bacteria, and Epiva Biosciences, another microbiome company from Flagship VentureLabs, merged to create a leading immuno-microbiome platform company in the U.S.
  • Medivation Inc., an American biopharmaceutical company working for the development of novel therapeutics, enters confidentiality agreement with French Drugmaker, Sanofi, who agreed to terminate its consent solicitation.
  • AstraZeneca is considering $10 billion bid for Medivation Inc., an American biopharmaceutical company, according to reports, however no formal offers have been made.
  • Evelo Biosciences, a pioneer in Oncobiotics, and Mayo Clinic, U.S.A. entered into an exclusive research collaboration for Immuno-microbiome Cancer Therapies, for advance development of cancer-associated bacteria library, a key platform discovery tool of the former for the development of onco-microbials to treat cancer.

Downloads

Article in PDF

Recent Articles
potential-of-cdk4-6-inhibitors
Articles

Dec 09, 2024

How CDK4/6 Inhibitors Are Changing the Cancer Treatment Paradigm?

celiac-disease-therapies-to-watch-out
Articles

Dec 06, 2024

Top 6 Celiac Disease Therapies Progressing in Mid-Stage Trials

medtech-news-for-zimmer-biomet-orthocell-hologic
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Dec 05, 2024

FDA Approves Zimmer Biomet’s Oxford® Cementless Partial Knee; ReCerf® Sets Milestone as First All-Ceramic Hip Resurfacing Approved Worldwide; Orthocell Achieves US FDA 510(k) Clearance Milestone for Remplir Regulatory Study; Hologic’s Research Shows AI Breast Imaging Maintains Performance Across All Demographics; GE HealthCare Expands MRI Capabilities with Sonic DL’s Advanced Deep Learning; Terumo Unveils the R2P NaviCross Peripheral Support Catheter

Diagnostic Imaging Equipment
Hip Replacement Devices
Magnetic Resonance Imaging Devices
medical device
Medical Devices Market
MedTech Market
Nerve Repair and Regeneration
Partial Knee Arthroplasty
Peripheral Vascular Interventions
loader